Cita APA

Brabers, A. E., Moors, E. H., van Weely, S., & de Vrueh, R. L. (2011). Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe? BioMed Central.

Chicago Style Citation

Brabers, Anne EM, Ellen HM Moors, Sonja van Weely, i Remco LA de Vrueh. Does Market Exclusivity Hinder the Development of Follow-on Orphan Medicinal Products in Europe? BioMed Central, 2011.

Cita MLA

Brabers, Anne EM, Ellen HM Moors, Sonja van Weely, i Remco LA de Vrueh. Does Market Exclusivity Hinder the Development of Follow-on Orphan Medicinal Products in Europe? BioMed Central, 2011.

Atenció: Aquestes cites poden no estar 100% correctes.